Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1632 1648 1671 1672
This examiner grants 69% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19217607 | VECTOR-BASED GENE THERAPY FOR ELONGATOR ACETYLTRANSFERASE COMPLEX SUBUNIT 1 (ELP1) | Non-Final OA | University of Massachusetts |
| 17925179 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING A SARS-COV-2 INFECTION | Non-Final OA | EMORY UNIVERSITY |
| 18689602 | LONG-TERM SURROGATE VIRUS ASSAYS AND METHODS | Non-Final OA | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 18000772 | MODIFIED ALPHAVIRUS FOR USE AS COVID-19 VACCINE | Non-Final OA | New York University |
| 18268156 | CORONAVIRUS RAPID DIAGNOSTICS | Non-Final OA | Massachusetts Institute of Technology |
| 18027067 | NUCLEIC ACID DETECTION USING A NUCLEASE ACTUATOR | Non-Final OA | The Johns Hopkins University |
| 17917058 | ASSAY TO DETECT VIRUS | Non-Final OA | CORNELL UNIVERSITY |
| 18032052 | VACCINATION OF HEMATOPOIETIC STEM CELL DONORS WITH CYTOMEGALOVIRUS TRIPLEX COMPOSITION | Non-Final OA | CITY OF HOPE |
| 18557247 | RECOMBINANT CEDAR VIRUS CHIMERAS | Final Rejection | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. |
| 17813762 | CANCER VACCINES AND METHODS OF TREATMENT USING THE SAME | Non-Final OA | Inovio Pharmaceuticals, Inc. |
| 17293861 | VECTORS COMPRISING A NUCLEIC ACID ENCODING LYSOSOMAL ENZYMES FUSED TO A LYSOSOMAL TARGETING SEQUENCE | Non-Final OA | ASKBIO INC. |
| 18003858 | GORILLA ADENOVIRUS NUCLEIC ACID- AND AMINO ACID-SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREOF | Final Rejection | REITHERA SRL |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy